相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interim results from PURE-01: A phase 2, open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC).
Andrea Necchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2017)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combining radiotherapy with immunotherapy: the past, the present and the future
Evert J. Van Limbergen et al.
BRITISH JOURNAL OF RADIOLOGY (2017)
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Joaquin Bellmunt et al.
CANCER TREATMENT REVIEWS (2017)
Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
Jeffrey J. Leow et al.
EUROPEAN UROLOGY (2014)
Treatment of Patients With Metastatic Urothelial Cancer Unfit for Cisplatin-Based Chemotherapy
Matthew D. Galsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study
Fumitaka Koga et al.
BJU INTERNATIONAL (2009)
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma:: results of a phase I/II trial
S. Lorenzen et al.
BRITISH JOURNAL OF CANCER (2008)
Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era
Richard E. Hautmann et al.
JOURNAL OF UROLOGY (2006)
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
Atreya Dash et al.
CANCER (2006)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
分享论文
